Swiss pharmaceutical group Novartis said Tuesday that it would invest 1.0 billion dollars (680 million euros) in research and development in China to latch on to growing demand for health care.
Jubilant Organosys, India has joined hands with the University of Alabama and Southern Research Institute, to develop affordable therapies for a range of metabolic and infectious diseases.
The international phama industry will see profits eroding for some more time to come, according to the Moody’s Investors Service. The noted credit rating
European approval for Visanne, a drug which treats the gynecological disease endometriosis has been obtained, according to German pharmaceutical and chemical group Bayer.
One of India’s leading pharmaceutical companies, Aurobindo Pharma has bagged approval from the US Food and Drug Administration for its anti-allergic Cetirizine Hydrochloride Syrup.
The social networking site Facebook is posing a huge problem to employers, who have noticed employees spending many working hours on facebook, and not matching expected productivity.
US pharma giant Pfizer and India’s Strides Arcolab have announced a new collaboration to commercialize off-patent sterile injectable and oral products in the United States.
Wockhardt Limited has announced that it has received tentative approval from the US Food and Drug Administration for marketing market Memantine tablets in the strength of 5 mg and 10 mg.
The European Union’s framework for evaluating policy options was shaped by British American Tobacco (BAT), the world’s second largest tobacco transnational,
Pharma major GlaxoSmithKline (GSK) is to reveal previously confidential data on thousands of potential anti-malaria compounds. The move will, hopefully,